BeOne Medicines (ONC) Cash from Operations (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Cash from Operations data on file, last reported at 201336000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations rose 356.73% year-over-year to 201336000.0 in Q1 2026; TTM through Mar 2026 was 1284834000.0, a 505.99% increase from a year earlier, with the FY2025 full-year figure at 1127580000.0, up 901.8% from the prior year.
• Cash from Operations for Q1 2026 stood at 201336000.0, down from 417347000.0 in the prior quarter.
• Over the last five years, Cash from Operations for ONC reached as high as 417347000.0 in Q4 2025 and fell as low as 563777000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 86222764.71 across 5 years, with a median of 95588000.0 in 2024.
• Across the five-year window, Cash from Operations slumped 350.36% in 2022 and jumped 455.28% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 318191000.0 in 2022, then surged by 30.34% to 221638000.0 in 2023, then surged by 133.91% to 75160000.0 in 2024, then soared by 455.28% to 417347000.0 in 2025, then sank by 51.76% to 201336000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 201336000.0 in Q1 2026, 417347000.0 in Q4 2025, and 402553000.0 in Q3 2025.